Jupiter Acquisition Corporation (NASDAQ:JAQC) (“Jupiter”) today
announced that it intends to reconvene and then adjourn, without
conducting any business, the special meeting of stockholders of
Jupiter (the “Business Combination Special Meeting”) scheduled to
reconvene on Tuesday, December 12, 2023, at 12:00 p.m. Eastern
Time, until Monday, December 18, 2023, at 12:00 p.m. Eastern Time,
as a completely virtual meeting conducted via live webcast, which
will be available at
https://www.cstproxy.com/jupiteracquisitioncorp/sm2023. At the
Business Combination Special Meeting, once further reconvened,
stockholders of Jupiter will be asked to vote on the proposals
described in the definitive proxy statement/prospectus filed by
Jupiter with the U.S. Securities and Exchange Commission (the
“SEC”) on November 13, 2023 (as further amended or supplemented,
the “definitive proxy statement/prospectus”), relating to the
proposed business combination (the “Proposed Business Combination”)
between Jupiter and Filament Health Corp., a corporation organized
under the laws of British Columbia (“Filament”).
If you properly submitted public shares for
redemption in connection with the Business Combination Special
Meeting, such shares will be redeemed if Jupiter implements the
proposed extension of time to complete an initial business
combination in connection with the separate special meeting of
stockholders of Jupiter (the “Extension Special Meeting”) scheduled
to be held on Thursday, December 14, 2023 at 12:00 p.m. Eastern
Time. If you do not wish to have such public shares redeemed, you
must contact Jupiter’s transfer agent prior to the Extension
Special Meeting. Information about the procedures for redemption or
withdrawing redemptions is included in the definitive proxy
statement/prospectus, which is available without charge on the
SEC’s website at https://www.sec.gov.
About Jupiter Acquisition Corporation
Jupiter is a blank check company formed for the
purpose of effecting a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business
combination with one or more businesses.
Important Information
About the Proposed Business Combination and Where to Find
It
This communication relates to the Proposed
Business Combination between Jupiter and Filament and may be deemed
to be solicitation material in respect of the Proposed Business
Combination. The Proposed Business Combination will be submitted to
Jupiter’s stockholders for their consideration and approval.
1427702 B.C. Ltd., a corporation organized under the laws of
British Columbia (“TopCo”), has filed a registration statement on
Form F-4 (File No. 333-273972) and amendments and supplements
thereto (the “Registration Statement”) with the SEC, which contains
a preliminary proxy statement/prospectus that constitutes (i) a
preliminary proxy statement in connection with Jupiter’s
solicitation of proxies for the vote by Jupiter’s stockholders to
approve the Proposed Business Combination and other matters as
described in the Registration Statement and (ii) a preliminary
prospectus relating to the offer of TopCo securities to be issued
in the Proposed Business Combination. The Registration Statement
was declared effective by the SEC on November 13, 2023, and TopCo
and Jupiter filed the definitive proxy statement/prospectus with
the SEC on that same date. Jupiter and TopCo also intend to file
other relevant documents with the SEC and, in the case of Filament
and TopCo, with the applicable Canadian securities regulatory
authorities, regarding the Proposed Business Combination. On
November 13, 2023, after the Registration Statement was declared
effective, Jupiter commenced the mailing of the definitive proxy
statement/prospectus and other relevant documents to its
stockholders as of the record date established for voting on the
Proposed Business Combination. The Proposed Business Combination
will also be submitted to the securityholders of Filament for their
consideration and approval. JUPITER’S STOCKHOLDERS AND OTHER
INTERESTED PERSONS ARE ADVISED TO READ THE REGISTRATION STATEMENT,
THE PRELIMINARY PROXY STATEMENT/PROSPECTUS AND THE DEFINITIVE PROXY
STATEMENT/PROSPECTUS, AND ANY AMENDMENTS OR SUPPLEMENTS THERETO, IN
CONNECTION WITH JUPITER’S SOLICITATION OF PROXIES FOR ITS SPECIAL
MEETING OF STOCKHOLDERS TO BE HELD TO APPROVE, AMONG OTHER THINGS,
THE PROPOSED BUSINESS COMBINATION, BECAUSE THESE DOCUMENTS CONTAIN
OR WILL CONTAIN IMPORTANT INFORMATION ABOUT JUPITER, FILAMENT,
TOPCO AND THE PROPOSED BUSINESS COMBINATION.
Jupiter’s stockholders and other interested
parties may also obtain a copy of the Registration Statement, the
preliminary proxy statement/prospectus and the definitive proxy
statement/prospectus, and any amendments or supplements thereto, as
well as other documents filed with the SEC regarding the Proposed
Business Combination and other documents filed with the SEC by
Jupiter, without charge, at the SEC’s website located at
www.sec.gov, or by directing a request to: Jupiter Acquisition
Corporation, 11450 SE Dixie Hwy, Suite 105, Hobe Sound, FL 33455.
As the Registration Statement contains certain information about
Filament, the Registration Statement has also been made available
under Filament’s profile on SEDAR at www.sedar.com.
INVESTMENT IN ANY SECURITIES DESCRIBED
HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER
REGULATORY AUTHORITY, NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED
THE MERITS OF THE PROPOSED BUSINESS COMBINATION PURSUANT TO WHICH
ANY SECURITIES ARE TO BE OFFERED OR THE ACCURACY OR ADEQUACY OF THE
INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS
A CRIMINAL OFFENSE.
Forward-Looking Statements
This communication includes “forward-looking
statements” within the meaning of the “safe harbor” provisions of
the United States Private Securities Litigation Reform Act of 1995
and forward-looking information within the meaning of applicable
Canadian securities laws. Forward-looking statements may be
identified by the use of words such as “estimate,” “plan,”
“project,” “forecast,” “intend,” “will,” “expect,” “anticipate,”
“believe,” “could,” “continue,” “may,” “might,” “outlook,”
“possible,” “potential,” “predict,” “scheduled,” “should,” “would.”
“seek,” “target” or other similar expressions that predict or
indicate future events or trends or that are not statements of
historical matters, but the absence of these words does not mean
that a statement is not forward-looking. Generally, statements that
are not historical facts, including statements concerning possible
or assumed future actions, business strategies, events or results
of operations, and any statements that refer to projections,
forecasts or other characterizations of future events or
circumstances, including any underlying assumptions, are
forward-looking statements. These statements are based on various
assumptions, whether or not identified in this communication, and
on the current beliefs and expectations of Filament’s, TopCo’s and
Jupiter’s management and are not predictions of actual performance.
These forward-looking statements are provided for illustrative
purposes only and are not intended to serve as and must not be
relied on by any investor as a guarantee, an assurance, a
prediction, or a definitive statement of fact or probability.
Although Filament, TopCo and Jupiter believe that their respective
plans, intentions, and expectations reflected in or suggested by
these forward-looking statements are reasonable, none of Filament,
TopCo or Jupiter can assure you that any of them will achieve or
realize these plans, intentions, or expectations. Actual events and
circumstances are difficult or impossible to predict and will
differ from assumptions. Many actual events and circumstances are
beyond the control of Filament, TopCo and Jupiter. These
forward-looking statements are subject to a number of risks and
uncertainties, including (i) the occurrence of any event, change or
other circumstances that could give rise to the termination of the
Proposed Business Combination; (ii) the failure of either Jupiter
or Filament prior to the Proposed Business Combination, or TopCo
after the Proposed Business Combination, to execute their business
strategy; (iii) the outcome of any legal proceedings that may be
instituted against Filament, TopCo or Jupiter or others following
the announcement of the Proposed Business Combination; (iv) the
inability to complete the Proposed Business Combination due to the
failure to obtain any necessary interim order or other required
court orders in respect of Filament’s statutory plan of arrangement
under the Business Corporations Act (British Columbia) with respect
to the Proposed Business Combination or the failure to obtain the
approval of Filament’s shareholders or Jupiter’s stockholders or to
satisfy other conditions to closing; (v) changes to the proposed
structure of the Proposed Business Combination that may be required
or appropriate as a result of applicable laws or regulations or as
a condition to obtaining regulatory approval of the Proposed
Business Combination; (vi) the ability to meet stock exchange
listing standards prior to and following the consummation of the
Proposed Business Combination; (vii) the risk that the Proposed
Business Combination disrupts current plans and operations of
Filament as a result of the announcement and consummation of the
Proposed Business Combination; (viii) the ability to recognize the
anticipated benefits of the Proposed Business Combination, which
may be affected by, among other things, competition and the ability
of TopCo to grow and manage growth profitably, maintain
relationships with customers and retain its management and key
employees; (ix) costs related to the Proposed Business Combination;
(x) failure to comply with and stay abreast of changes in laws or
regulations applicable to Filament’s business, including health and
safety regulations and policies; (xi) Filament’s estimates of
expenses and profitability and underlying assumptions with respect
to redemptions by Jupiter’s stockholders and purchase price and
other adjustments; (xii) any downturn or volatility in economic or
business conditions; (xiii) the effects of COVID-19 or other
epidemics or pandemics; (xiv) changes in the competitive
environment affecting Filament or its customers, including
Filament’s inability to introduce, or obtain regulatory approval
for, new products; (xv) the failure to obtain additional capital on
acceptable terms; (xvi) the impact of pricing pressure and erosion;
(xvii) failures or delays in Filament’s supply chain; (xviii)
Filament’s ability to protect its intellectual property and avoid
infringement by others, or claims of infringement against Filament;
(xix) the possibility that Filament, TopCo or Jupiter may be
adversely affected by other economic, business and/or competitive
factors; (xx) the failure of Filament or TopCo to respond to
fluctuations in foreign currency exchange rates; and (xxi)
Filament’s estimates of its financial performance; and those
factors discussed in documents of Jupiter or TopCo filed, or to be
filed, with the SEC. If any of these risks materialize or any
assumptions prove incorrect, actual results could differ materially
from the results implied by these forward-looking statements. There
may be additional risks that none of Filament, TopCo or Jupiter
presently knows or that Filament, TopCo and Jupiter currently
believe are immaterial that could also cause actual results to
differ from those contained in the forward-looking statements. In
addition, forward-looking statements reflect Filament’s, TopCo’s
and Jupiter’s expectations, plans, or forecasts of future events
and views as of the date of this communication. Filament, TopCo and
Jupiter anticipate that subsequent events and developments will
cause Filament’s, TopCo’s and Jupiter’s assessments to change.
However, while Filament, TopCo and Jupiter may elect to update
these forward-looking statements at some point in the future,
Filament, TopCo and Jupiter specifically disclaim any obligation to
do so. These forward-looking statements should not be relied upon
as representing Filament’s, TopCo’s or Jupiter’s assessments as of
any date after the date of this communication. Accordingly, undue
reliance should not be placed upon the forward-looking
statements.
No Offer or Solicitation
This communication does not constitute an offer
to sell or the solicitation of an offer to buy any securities or a
solicitation of any vote or approval, nor shall there be any sale
of securities in any jurisdiction in which such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction.
No offering of securities shall be made except by means of a
prospectus meeting the requirements of Section 10 of the U.S.
Securities Act of 1933, as amended (the “Securities Act”), or
pursuant to an exemption from the Securities Act. In Canada, no
offering of securities shall be made except by means of a
prospectus in accordance with the requirements of applicable
Canadian securities laws or an exemption therefrom. This
communication is not, and under no circumstances is it to be
construed as, a prospectus, offering memorandum, an advertisement
or a public offering in any province or territory of Canada. In
Canada, no prospectus has been filed with any securities commission
or similar regulatory authority in respect of any of the securities
referred to herein.
Participants in Solicitation
Jupiter, Filament, TopCo, and certain of their
respective directors, executive officers, and other members of
management and employees may, under SEC rules, be deemed to be
participants in the solicitations of proxies from Jupiter’s
stockholders in connection with the Proposed Business Combination.
Information regarding Jupiter’s directors and executive officers is
available in its Annual Report on Form 10-K for the fiscal year
ended December 31, 2022, which was filed with the SEC on March 10,
2023. Information regarding the persons who may, under SEC rules,
be deemed participants in the solicitation of proxies from
Jupiter’s stockholders in connection with the Proposed Business
Combination is set forth in the Registration Statement, and the
preliminary proxy statement/prospectus included therein, and the
definitive proxy statement/prospectus. Additional information
regarding the participants in the proxy solicitation and a
description of their direct and indirect interests is included in
the Registration Statement, and the preliminary proxy
statement/prospectus included therein, and is included in the
definitive proxy statement/prospectus. Jupiter’s stockholders,
potential investors, and other interested persons should carefully
read the Registration Statement, the preliminary proxy
statement/prospectus and the definitive proxy statement/prospectus,
and any amendments or supplements thereto, and related documents
filed with the SEC, before making any voting or investment
decisions. These documents, once available, can be obtained free of
charge from the sources indicated above.
No Assurances
There can be no assurance that the Proposed
Business Combination will be completed, nor can there be any
assurance, if the Proposed Business Combination is completed, that
the potential benefits of the Proposed Business Combination will be
realized.
Contacts
James N. Hauslein, Chairman and Chief Executive
Officerjim@hauslein.com
Jupiter Acquisition (NASDAQ:JAQC)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Jupiter Acquisition (NASDAQ:JAQC)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024